-
admin
Posts
Tuya Inc. to Hold Annual General Meeting on June 18, 2026
SANTA CLARA, Calif., May 14, 2026 /PRNewswire/ — Tuya Inc. (“Tuya” or the “Company”) (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service...
MDJM Ltd. (OTC: UOKAF) Enters into Share Purchase Agreement to Acquire Controlling Stake in Japan-Based Mirai Co., Ltd.
LETHAM, Scotland, May 14, 2026 /PRNewswire/ — MDJM Ltd. (OTC: UOKAF) (the “Company”), an integrated global culture-driven asset management company, today announced that, through its wholly-owned...
Chop Steakhouse & Bar Brings a Modern Steakhouse Experience to South Surrey
New location opening soon at Grandview Corners, featuring a four-season patio and private dining for every occasion SURREY, British Columbia, May 13, 2026 (GLOBE NEWSWIRE)...
MINILUXE ANNOUNCES NON-BROKERED PRIVATE PLACEMENT OF US$3.5 TO US$5 M (CAD $4.8M to CAD $6.0M)
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Company initiates non-brokered private placement at a premium to...
Nasal Splints Market Size to be Worth USD 4.06 Billion by 2035; Growth is Driven by Increasing Number of Nasal Surgeries Globally | SNS Insider
U.S. Nasal Splints Market is expected to grow from USD 0.74 billion in 2025 to USD 1.16 billion in 2035 due to rising volumes of...
DutyFreeAlibaba.com and AlibabaDutyFree.com Announce Global Vendor, Wholesale & Investor Enrollment Ahead of Fall 2026 Launch
Bringing the Alibaba-Style Marketplace Concept to the Global Duty-Free World MIAMI, May 13, 2026 (GLOBE NEWSWIRE) — DutyFreeAlibaba.com and AlibabaDutyFree.com, two next-generation digital marketplace platforms...
Candel Therapeutics to Present at Upcoming Investor Conferences
NEEDHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment...
Century Therapeutics Reports First Quarter Financial Results and Business Updates
CNTY-813, Century’s type 1 diabetes iPSC-derived islet therapy with functional-cure potential, remains on track for IND in 4Q 2026; initial clinical data expected in 2H...
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at...
